rts,s
Trade name: Mosquirix
Vaccineexperimental
Clinical trial activity
15 trials · 16 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
13
Phase 3
2
Phase 4
1
Earliest trial started Apr 1, 2001 (NCT01556945)
Timeline
Indications
Approved for
Mechanism of action
- Plasmodium vivaxImmunity, active
Plasmodium vivax immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rts,s
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07036159 | Phase 2 | Aug 6, 2025 | Center for Family Health Research (CFHR), GlaxoSmithKline |
| NCT06424002 | Phase 4 | Jun 1, 2024 | Boston University, Government of Malawi, Kamuzu University of Health Sciences, Michigan State University |
| NCT04319380 | Phase 3 | May 31, 2020 | Institut de Recherche en Sciences de la Santé, Direction Régionale de l'Ouest (IRSS-DRO), Institut et Haute école de la Santé, La Source, Malaria Research and Training Center, Bamako, Mali, University of London |
| NCT02992119 | Phase 2 | Jun 4, 2017 | Mahidol University, University of Oxford |
| NCT03162614 | Phase 2 | May 23, 2017 | GlaxoSmithKline, PATH |
| NCT03143218 | Phase 3 | Apr 17, 2017 | Institut et Haute école de la Santé, La Source, Malaria Research and Training Center, Bamako, Mali, University of London |
| NCT02252640 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2015 | National Institute for Health Research, United Kingdom, PATH, University of Oxford |
| NCT01883609 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2013 | Moorgreen Hospital, Southampton, University of London, University of Oxford |
| NCT00289185 | Phase 2 | Sep 27, 2006 | GlaxoSmithKline |
| NCT00197028 | Phase 2 | Aug 23, 2005 | GlaxoSmithKline |
| NCT00197054 | Phase 2 | Jul 1, 2005 | GlaxoSmithKline, United States Army |
| NCT00197067 | Phase 1 | Mar 15, 2004 | GlaxoSmithKline |
| NCT00075049 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2003 | GlaxoSmithKline, United States Army |
| NCT00197041 | Phase 2 | Jul 1, 2003 | GlaxoSmithKline |
| NCT01556945 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2001 | GlaxoSmithKline, United States Army |
Showing 15 of 15 trials
Page 1 / 1
Organizations
Research & Development (16)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 9 | 6 | 2 | 2001 |
| United States Army | Government | 3 | 3 | 1 | 2001 |
| University of London | Academic/Hospital | 3 | 2 | 2 | 2013 |
| University of Oxford | Academic/Hospital | 3 | 3 | 1 | 2013 |
| Institut et Haute école de la Santé, La Source | Academic/Hospital | 2 | 0 | 1 | 2017 |
| Malaria Research and Training Center, Bamako, Mali | Academic/Hospital | 2 | 0 | 1 | 2017 |
| PATH | Academic/Hospital | 2 | 0 | 1 | 2015 |
| Boston University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Center for Family Health Research (CFHR) | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Government of Malawi | Government | 1 | 0 | 1 | 2024 |
| Institut de Recherche en Sciences de la Santé, Direction Régionale de l'Ouest (IRSS-DRO) | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Kamuzu University of Health Sciences | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Mahidol University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Michigan State University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Moorgreen Hospital, Southampton | Academic/Hospital | 1 | 0 | 1 | 2013 |
| National Institute for Health Research, United Kingdom | Government | 1 | 0 | 1 | 2015 |
16 organizations
Page 1 / 1